FDA approves oral drug meant to help reduce LDL cholesterol | News
Alex Green Washington, D.C. — The U.S. Food and Drug Administration (FDA) has announced the approval of Lipfendra…
Mounjaro prescriptions top 1.5 mil. in 10 months, teen use surges
Eli Lilly’s obesity treatment drug Mounjaro / Courtesy of Eli Lilly Obesity treatment drug Mounjaro has been prescribed…
People with MS in England to be given fampridine as patent expires
Adults with multiple sclerosis (MS) and associated walking impairment in England are now eligible for NHS treatment with…
Pharmacist issues ‘arrest’ warning for anyone taking common meds abroad
Drugs issued by prescription, and even some bought over the counter in the UK, are banned abroad Neil…
Simtriyo (Centanafadine) for ADHD: How It Works and Side Effects
People with ADHD who don’t do well or see enough symptom improvement with existing drugs have a new…
Doctors share warning about how impact extreme summer heat can interact with everyday medications
As temperatures continue to rise across Georgia, doctors and pharmacists are issuing a reminder about mixing medicine with…
Mental Health Effects of GLP-1 Medications
Glucagon-like peptide-1 (GLP-1) is a hormone that helps regulate blood glucose levels, slow digestion, and promote a sense…
FDA Approves Fast-Acting Acetaminophen-Naproxen Combo for Pain Relief
Share on PinterestA new fast-acting pain relief medication contains the active ingredients acetaminophen (Tylenol) and naproxen (Aleve). Photo…
Popular Antihistamine Tablets Recalled Due to Potential Cross-Contamination That May Be Life-Threatening: FDA
NEED TO KNOW Unique Pharmaceuticals recalled four lots of cetirizine hydrochloride tablets due to potential contamination with ranitidine…
FDA approves Tylenol with Naproxen OTC combo
(Gray News) – The first fixed-dose combination of acetaminophen (Tylenol) and naproxen sodium was approved by the FDA.…
FDA approves Tylenol with Naproxen OTC combo
(Gray News) – The first fixed-dose combination of acetaminophen (Tylenol) and naproxen sodium was approved by the FDA.…
Fixed-dose inotuzumab ozogamicin (INO) combined with Vincristine and Prednisone (VP) regimen as induction therapy for newly diagnosed B-cell acute lymphocytic leukemia (B-ALL): a multi-center, open-label, single-arm, prospective clinical study
Adult B-ALL exhibits significant heterogeneity and poor prognosis compared with the pediatric population. While the complete remission (CR)…